======= ALDH1L2 =======
== Gene Information ==
* **Official Symbol**: ALDH1L2
* **Official Name**: aldehyde dehydrogenase 1 family member L2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=160428|160428]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q3SY69|Q3SY69]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ALDH1L2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ALDH1L2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/613584|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of both the aldehyde dehydrogenase superfamily and the formyl transferase superfamily. This member is the mitochondrial form of 10-formyltetrahydrofolate dehydrogenase (FDH), which converts 10-formyltetrahydrofolate to tetrahydrofolate and CO2 in an NADP(+)-dependent reaction, and plays an essential role in the distribution of one-carbon groups between the cytosolic and mitochondrial compartments of the cell. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2010].
* **UniProt Summary**: N/A
|Aldedh|
|Formyl trans C|
|Formyl trans N|
|hydroxymethyl-, formyl- and related transferase activity|
|formyltetrahydrofolate dehydrogenase activity|
|10-formyltetrahydrofolate catabolic process|
|folic acid-containing compound catabolic process|
|pteridine-containing compound catabolic process|
|10-formyltetrahydrofolate metabolic process|
|aldehyde dehydrogenase (NAD) activity|
|coenzyme catabolic process|
|dicarboxylic acid catabolic process|
|tetrahydrofolate metabolic process|
|folic acid metabolic process|
|one-carbon metabolic process|
|folic acid-containing compound metabolic process|
|cellular modified amino acid catabolic process|
|pteridine-containing compound metabolic process|
|cofactor catabolic process|
|water-soluble vitamin metabolic process|
|dicarboxylic acid metabolic process|
|vitamin metabolic process|
|cellular modified amino acid metabolic process|
|coenzyme metabolic process|
|carboxylic acid catabolic process|
|organic acid catabolic process|
|mitochondrial matrix|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|small molecule catabolic process|
|cofactor metabolic process|
|aromatic compound catabolic process|
|organic cyclic compound catabolic process|
|drug metabolic process|
|cellular amide metabolic process|
|carboxylic acid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|organic acid metabolic process|
|organonitrogen compound catabolic process|
|mitochondrion|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp350|Deferoxamine 11μM R07 exp350]]|-1.9|
|[[:results:exp46|HMS-I1 1μM R01 exp46]]|-1.88|
|[[:results:exp54|Taxol 0.002μM R01 exp54]]|-1.78|
|[[:results:exp493|IL-3 9ng/ml R08 exp493]]|1.79|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 10901
* **Expression level (log2 read counts)**: 2.37
{{:chemogenomics:nalm6 dist.png?nolink |}}